chemical genomic profiling antimalarial therapies response signatures molecular targets 
malaria remains devastating disease largely widespread drug resistance new drugs better understanding mechanisms drug action resistance essential fulfilling promise eradicating malaria using high-throughput chemical screening genome-wide association analysis identified highly active compounds genetic loci associated differential chemical phenotypes dcps defined greater equal fivefold differences half-maximum inhibitor concentration ic50 parasite lines chromosomal loci associated dcps confirmed linkage analysis tests genetically modified parasites including three genes linked % dcps drugs whose responses mapped wild-type mutant pfcrt alleles tested combination vitro vivo yielded promising new leads antimalarial treatments 
